SHAHZAD AHMAD M.D F.A.C.E DIPLOMATE AMERICAN BOARD OF INTERNAL MEDICINE DIPLOMATE AMERICAN BOARD OF ENDOCRINOLOGY/DIABETES AND METABOLISM THYROID INSTITUTE.

Slides:



Advertisements
Similar presentations
Thyroid Cancer -- Papillary
Advertisements

Controversies in the Management of Differentiated Thyroid Carcinoma
Case 20 Thomas J. Giordano, M.D., Ph.D.. History A 54-year old man with a past medical history of goiter for approximately 4 years was followed by ultrasound.
Hong CM, Ahn BC, Jeong SY, Lee SW, Lee J
The Thyroid Incidentaloma
APPROACH TO A CASE OF THYROID NODULE
Surgical Thyroid Disease. Surgical Thyroid disease Presentation and assessment Indications for surgery Risks of surgery Thyroid cancer / RAI protocol.
Frank P. Dawry Thyroid Cancer Therapy Radioactive Iodine (I-131)
Lateral neck dissection for papillary thyroid cancer
D3 Tambal – Tolentino THYROID CA.
Management of Papillary Ca Thyroid
Papillary Microcarcinoma of the Thyroid T.T. Law Queen Mary Hospital Joint Hospital Surgical Grand Round 16th January, 2010.
Is the BRAF V600E mutation useful as a predictor of preoperative risk in papillary thyroid cancer? The American Journal of Surgery.
Thyroid nodule History History Physical examination Physical examination –Euthyroid –Hypothyroid –Hyperthyroid Labs Labs –TSH –(antibodies)
Radiology of Thyroid and parathyroid
Update in the Management of Thyroid Neoplasms University of Washington
Minimally Invasive Follicular Carcinoma: A Cytological and Histological Challenge David Poller, Queen Alexandra Hospital,Portsmouth, UK.
12 th G. Rainey Williams Surgical Symposium What Operation for Thyroid Cancer? Ronald Squires, MD FACS Associate Professor of Surgery Sections of General.
Joint Hospital Surgical Grand Round PYNEH, 18th April 2015
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Approach.
Clinical Utility of Combidex in Various Cancers
Management of differentiated thyroid cancer Dr. Leung Tak Lun Canice North District Hospital.
Focus on endocrine neoplasia July 9, 2010 Rome Furio Pacini Dipartimento di Medicina Interna e Scienze Endocrino-Metaboliche Università di Siena Differentiated.
THYROID GLAND.
Role of Neck Dissection for Differentiated Thyroid CA Joint Hospital Surgical Grand Round NDH Dr. Alex TSANG.
Joint Hospital Surgical Grand Round United Christian Hospital
Vic V. Vernenkar, D.O. St. Barnabas Hospital Department of Surgery
Ian Hammond. Most likely diagnosis? a)Grave’s disease b)Hashimoto’s disease c)Multifocal papillary cancer d)Anaplastic thyroid cancer.
Ian Jaffee, MD FCAP Director of Cytopathology
THYROID TREATMENT AND VITAMIN D UPDATE A CPMC Regional CME Event - An Integrated Approach Saturday October 27, 2012.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
Solitary thyroid nodule Hystory Low dose radiation Family hystory Physical exam.
Risk Adapted Management of Thyroid Cancer R Michael Tuttle, MD Professor of Medicine Endocrine Service Memorial Sloan Kettering Cancer Center New York,
Case History: 68 Year old male patient was admitted to the nearest hospital for excision of a small basaliom on the skin of the face. By performing routine.
Thyroid Cancer 2005 Nancy Fuller, M.D. University of Wisconsin-Madison.
Update on 18 F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/ Computed Tomography Imaging of Squamous Head and Neck.
ד"ר חגי מזא"ה כירורגיה אנדוקרינית מבואות כירורגיה שנה ד'
Management of the Locoregional Recurrence in Well-differentiated Thyroid Carcinoma 陳漢文.
Approach to a thyroid nodule
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.
Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management J Nucl Med 2006; 47:616–624 報告者 : 蘇惠怡.
 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
Approach to the Thyroid Nodule
2010  Solitary thyroid nodules are present in approximately 4 percent of the population.  Thyroid cancer has a much lower incidence of 40 new cases.
Thyroid Nodules Hollis Moye Ray, MD SEAHEC Internal Medicine June 3, 2011.
Endocrine Pathology Lab
About these slides SPEC – Short Presentation in Emerging Concepts Provided by the CAP as an aid to pathologists to facilitate discussion on the topic.
WORK UP & MANAGEMENT OF SOLITARY PULMONARY NODULE Seifu B Oct-04, 2007.
IMAGING OF THE THYROID Dr Jill Hunt Consultant Radiologist West Herts NHS Trust.
Evaluation of Thyroid Nodules
BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.
3. What work ups are needed, if any?
1. Clinical Impression? Differentials?. Thyroid Carcinoma commonly manifests as a painless, palpable, solitary thyroid nodule The patient's age at presentation.
Thyroid disease By Dr Fahad.
Examination of Pathology Demonstration of Thyroid Nodules And the Post Thyroidectomy Neck.
Management of thyroid nodule.  Introduction.  Guidelines recommendation.  Thyroid nodule work up.  Medical therapy in thyroid nodule  Thyroid nodule.
Anaplastic thyroid cancer based on ATA guideline for Management of Patients with ATC. Thyroid. 2012;22: R3 이정록.
Thyroid Nodules ENDOCRINOLOGY DIVISION Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA.
Sonographic Extranodular and Intranodular Microcalcifications NIDHI AGRAWAL, MD VALERIE PECK, MD DIVISION OF ENDOCRINOLOGY, DIABETES AND METABOLISM NEW.
Clinical Oncology & Nuclear Medicine Dep.
J Clin Endocrinol Metab, Sep 2006, 91(9):

Management of Thyroid Nodules Detected at US: Society of Radiologists in Ultrasound Consensus Conference Statement Radiology 2005; 237: Presented.
Follicular variant of papillary thyroid carcinoma
Nuclear Radiology Thyroid
Radiology of Thyroid and parathyroid
Maria Belgun, L.Dumitriu, A.Goldstein, Mariana Purice, F.Alexiu
VALUES OF ELASTOGRAPHY IN DIAGNOSIS OF THYROID CANCER
Cheng-Chiao Huang, MD, MSc
Solitary Thyroid Nodule Aisha Abu Rashed
Presentation transcript:

SHAHZAD AHMAD M.D F.A.C.E DIPLOMATE AMERICAN BOARD OF INTERNAL MEDICINE DIPLOMATE AMERICAN BOARD OF ENDOCRINOLOGY/DIABETES AND METABOLISM THYROID INSTITUTE OF UTAH

Thyroid nodule discrete lesion in the thyroid gland radiologically distinct from the surrounding Thyroid Nonpalpable nodules are called “incidentilomas”

How Common are nodules? % if ultrasound is done

How common is Thyroid Cancer 5-15% depending on risk factors

Incidence of thyroid cancer has increased more than threefold. nearly 50% of the increased incidence is from tumors >2 cm, suggesting that a significant number of patients have clinically important tumors.

So you feel a nodule, now what

Nonpalpable nodules have the same risk of malignancy as palpable nodules with the same size

Who should you send for an ultrasound ? All patients with a suspected thyroid nodule, nodular goiter, a nodule found incidentally On (CT) or MRI or on PET scan. Anyone with a first degree relative with thyroid cancer

Generally, only nodules >1 cm should be evaluated Any thyroid lesion seen on PET scan should be evaluated by an Endocrinologist

appropriate evaluation of clinically or incidentally discovered thyroid nodule(s) Measure TSH If serum TSH is subnormal, radionuclide thyroid I-123 scan

RightLeft

TOXIC MNG

Normal TSH with Irregular gland

What will the u/s tell us ?

Hyperthyroidism Diffuse Goiter, thyroid stimualting immunoglobulin negative

Routine FNA is not recommended for subcentimeter nodules unless Family history of PTC history of external beam radiation 18FDGPET–positive thyroid nodules. Suspicious imaging charecteristics

long-term follow-up of patients with thyroid nodules? benign nodules require follow-up As there is a 5 % fasle negative rate its actually only 0.6% for u/s guided ! which may be even higher with nodules >4 cm

reasonable definition of growth is a 20% increase in nodule diameter serial US examinations 6–18 months after the initial FNA.

Cytology interpretation 6 follicular cell groups,10-15 cells each 7% of biopsies can be non diagnostic

Follicular neoplam Can be seen in 15-30% of biopsies If the cytology reading reports a follicular neoplasm, a 123I thyroid scan may be considered, if not already done, especially if the serum TSH is in the low-normal range

Indeterminate cytology/neoplasm Indeterminate cytology, reported as ‘‘follicular neoplasm’’ or ‘Hurthle cell neoplasm’’ can be found in 15–30% FNA’s carries a 10–30% risk of malignancy

If the cytology reading reports a follicular neoplasm, a 123I thyroid scan may be considered

The use of molecular markers (e.g., BRAF, RAS,RET=PTC, or galectin-3) may be considered for patients with indeterminate cytology Recommendation rating: C

Brief Discussion Of molecular markers BRAF V-600 E, associated with PTC, predicts aggressive course and lymph node mets Not associated with Radiation! Enviromental toxins?

FOLLICULAR CANCERS RAS MUTATION seen in approximately 40 percent of follicular cancers PAX8-PPAR gamma 1, seen in 10 percent of Follicular cancers

MOLECULAR ANALYSIS OF INDETERMINATE CYTOLOGY 1056 indeterminate FNA samples Assessed for- BRAF V600E, RAS,RET/PTC, PAX/PPAR False negative rate at surgery was 5.9% Finding of RAS mutation increased risk of Thyroid cancer to 80% J Clin Endocrinol Metab 2011;96:

Cystic nodules Recurrent cystic thyroid nodules with benign cytology should be considered for surgical removal or PEI Recommendation B

What is the role of medical therapy for benign thyroid nodules? Old time Endocrinologists are still using Thyroid hormone to “shrink” thyroid nodules

30 YEAR OLD FEMALE WITH MULTI NODULAR GOITER DISCOVERED SEPT 2006 ANTI-TPO 154, ANTI TG AB-368 TSH 7.36 FNA CONSISTENT WITH WELL DIFFERENTIATED PAPILARY THYROID CANCER ON THE RIGHT LEFT INDETERMINATE

Next step(s) ?

Preoperative Ultrasound ? Preoperative neck ultrasound for cervical lymph nodes is recommended for all patients undergoing thyroidectomy Use of CT/MRI/PET not recommended by the American Thyroid Association Cooper,D.S thyroid 16(2)

Ultrasonographic lymph node "map"

WHY TOTAL THYROIDECTOMY? Multiple Foci of PTC are found in thyroid lobes in up to 80 percent of patients Upto 40 % can be bilateral The only predictor of contra lateral cancer is multifocality in ipsilateral lobe Katoh R, sasaki, cancer ;70

What does the A.T.A recommend? NTT for bilateral nodules NTT if metastatic lymph nodes seen Age more than 45 Nodule more than 1 cm

Cervical recurrence occurs in up to 25% of patients with papillary thyroid carcinoma (PTC) The use of total thyroidectomy for most patients with thyroid carcinoma is supported by the following arguments:

NODE DISSECTION should be performed if there is clinical evidence of cervical or mediastinal node metastases due to the increased risk of neck recurrence and mortality Am J Med 1994 Nov;97(5): MAZAFFERI

Extent of surgery improves survival patients with NTT, Survival improved in tumours >1 cm Patients undergoing lobectomy had a 49% higher mortality rate 2007 Ann of surgery 246:375-

Threshold size for lymph node metastases 5mm for Pappilary thyroid cancer 20 mm for Follicular thyroid cancer Machens et al Cancer 103(11)

Radioactive iodine Indications Benefits Risks Dose?

NEAR TOTAL THYROIDECTOMY OCTOBER 2006 PATHOLOGY WELL DIFFERENTIATED MULTICENTRIC ( 4) TUMOUR FOCI WITHIN THYROID 0.8 CM AND 0.4 CM WERE THE LARGEST FOCI ONE LYMPH NODE DISSECTED, NEGATIVE FOR TUMOUR

POST – OP WHOLE BODY SCAN ON 12/21/26 SOLITARY TRACER OF INTENSE UPTAKE IN UPPER OUTER QUADRENT OF NECK RIGHT OF MIDLINE TSH WAS 150, ANTI TG ANTIBODY 292

REMNANT ABLATION 12/29/06 WITH 49.8 MILLICURIE POST TREATMENT SCAN 1/9/07 RIGHT NECK UPTAKE WORRISOME FOR METASTATIC FOCUS !!

HOW DO WE LOOK FOR RESIDUAL/RECURRENT DISEASE ?

C.T scan neck looking for recurrence/ persistent mass NEGATIVE !

SEARCH FOR RECURRENT/RESIDUAL DISEASE HYPOECHOIC MASS, LIKELY LYMPH NODE AP/T 0.7 CM !! SEARCH FOR RECURRSEARCH FOR RECURR

Now to evaluate this lymph node! What are my options? a) should we have this resected ? b) check a whole body scan at 6 months c) Biopsy it

Ultrasound characteristics of a benign lymph node FFlattened or oval ( AP/T < 0.5 EEchogenic Hilus HHilar Flow on Doppler

Best ultrasound criteria for malignancy Short to long axis diameter ratio of more than 0.5 It has 75 % sensitivity, 81 % specificity 79 % accuracy

Does size help predict a malignant lymph node? NO ! Size doesn’t matter, Border doesn’t help either

What's the Best Way to Detect Cancer Recurrence After a Thyroidectomy?

Cervical ultrasonography is the best way to detect early recurrent disease Albert B. Lowenfels, MD, Professor of Surgery Medscape General Surgery. 2007;

How sensitive is ultrasonography? Operator dependent Frasoldati et al reported cytology to be 84% sensitive and if combined with TG washout 95.6 % sensitive

Cervical Ultrasonography, A.T.A recommends cervical ultrasound at 6 and 12 months after surgery and then annually

Thyroglobulin measurement in washout fluid from F.N.A of neck lymph nodes Tg-FNAB more than 36 ng/ml in the presence of thyroid gland, Tg-FNAB of more than 1.7 ng/ml in the absence of thyroid gland INDICATIVE OF METASTASIS J Clin Endocrinol Metab Apr;91(4): Epub 2006 Jan 24 Boi F, Boi F Baghino GBaghino G,

Clinical performance of Tg-FNAB appears to be not substantially affected by TgAb J Clin Endocrinol Metab Apr;91(4): Epub 2006 Jan 24 Boi FBoi F, Baghino GBaghino G,

ULTRASOUND+TG vs. DxWBS rhTSH -TG (%) Diagnostic WBS (%) rhTSH-TG + US LOW RISK HIGH RISK

rhTSH TG with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid cancer ! Pacini, F J clin Endocrinol, Met 2003

Comparison of cytology and TG washout

European Journal Of Endocrinology 2007, Cunha et al

“The data will be tortured untill they confess”

WHAT DOES THE DATA REALLY SAY Both Central and ipsilateral Lymph Nodes are affected commonly even with small PTCs Skip lesions ( involvement of lateral lymph nodes without central involvement) is RARE

PATIENTS WITH MULTIFOCAL TUMOURS MUCH MORE LIKELY TO HAVE LYMPH NODE METASTASIS MORTALITY HIGHER IN PATIENTS WITH MULTIFOCAL INTRATHYROIDAL TUMOUR AMERICAN JOURNAL OF MEDICINE 1997 VOL 97 MAZZAFERI ET AL

CONCLUSIONS (OPINION) PRE-OP NECK ULTRASOUND TO EVAULATE COTRALATERAL LOBE AND LYMPH NODES (AACE RECOMMENDATION LEVEL B) BIOPSY SUSPICIOUS LYMPH NODES (CYTOLOGY AND TG-WASHOUT) BASED ON MORPHOLOGY TO HELP SURGEONS DECIDE ABOUT NECK DISSECTION

MULTIFOCAL MICRO PTC MORE LIKELY TO HAVE LYMPH NODE METS PROBABLY SHOULD HAVE CENTRAL COMPARTMENT DISSECTION THIS WILL IMPACT RECURRENCE NO LONG TERM OUTCOMES DATA AVAILABLE

We should concentrate on mid-lower central compartment to avoid recurrence IN HIGHER RISK PATIENTS

DID ALL THIS SURGERY AFFECT LONG TERM OUTCOME? Recurrence was followed for 53 months in a japanese study One group of patients had prophylactic lymph node resection, the other only therapeutic Recurrence rate was 16.7 % lower in the group with therapeutic lymp node resection Patients with no palpable lymph nodes who had prophylactic dissection had a much lower recurrence rate- 0.4 %

Case 2  32 y/o male with Papillary thyroid cancer 1999  NTT pathology showed 4.5 x2.6 x 2.0 cm mass  Multi focal  Multiple lymph nodes positive, bilaterally  T3 N1B MX

Remnant Ablation 152 mCi dose of I-131 given 12/1999 Lost to follow up until 2006 Repeat WBS and PET negative

2007 On synthroid 225 mcg TSH 0.30 Thyroglobulin AB 0.7 IU/ML (range 0 to 14.4) Thyroglobulin 5.4 ng/ml

Looking for disease Repeat Surveillance WBS scan negative

NOW WHAT ? Role of ultrasound

WHERE AND WHEN DOES RECURRECE OCCUR 79 % RECURRENCE OCCURS IN THE NECK 74 % OF RECURRENCE IS IN THE LYMPH NODES TIME TO RECURRENCE USUALLY VARIES, SOME CASES RECUR AT 7-10 YEARS AMERICAN JOURNAL OF MEDICINE 1997 VOL 97 MAZZAFERI ET AL

HIGH SERUM THYROGLOBULIN NEGATIVE IMAGING ! LIKELY DUE TO A)CERVICAL LYMPH NODE METASTASIS B) METASTASIS TOO SMALL TO BE SEEN ON DxWBS OR RxWBS

Higher Thyroglobulin level means a higher chance of detection of mets/mass In patients with TG > 5 after rhTSH ultrasound picked up neck masses/mets in 67 % patients

Cystic metastatic lymph nodes 20 % of patients with Thyroid Cancer present with the sole finding of an abnormal lymph node Cystic metastasis cause most of the non- diagnostic lymph node biopsies Use a THYROGLUBULIN washout to prevent this from happening !

POST THYROIDECTOMY NECK  MEDIAL MOVEMENT OF CAROTID AND JUGULAR  Thyroid bed is filled with HYPER echoic connective tissue  This demarcates it from recurrence or metastatic lymph nodes which will be HYPO echoic

AP/T 0.79/1.45= 0.54 !

PET/CT IN TG +ve, SCAN NEGATIVE PATIENTS which is better, PET scan OR PET/CT Palmedo et al Journal of Nuclear Medicine Vol. 47 No

PET/CT IMPACT ON MANAGMENT PET PET/CT Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%) Palmedo ET AL 2006 Journal of Nuclear Medicine Vol. 47 No

Limitations PET/C.T will miss small lymph nodes which might be malignant

PET/CT with a suppressed TSH vs. rhTSH stimulated PET/CT Which is better?

Higher Thyroglobulin level means a higher chance of detection of mets/mass In patients with TG > 5 after rhTSH ultrasound picked up neck masses/mets in 67 % patients

Elastography ! Imaging Modality to map elastic properties of tissue Compression is done and strain distributed is checked on ultrasound Results are displayed on an elastogram Lyschick et al, Radiology april 2007

Stiff objects appear dark and flexible objects are bright ! Neck lymph nodes are in a great position for this technique to be applied Lyschick et al, Radiology april 2007

How accurate is it ? Elastography 98 % specificity 92% accuracy Other ultrasound criteria AP/ T ratio, vascularity,calcification 81 % specific 79% Lyschick et al, Radiology April 2007

Metastatic lymph nodes why they matter

PYTHIAN LYMPH NODES Pythia was the priestess of Delphi, whose utterence was ambiguous and interpretable in different ways what happens to these lymph nodes some may grow and become significant Some may metastasize Some may remain dormant and surgery not needed

AFTER thyroidectomy and RAI ablation how often do patients have residual disease?

% have disease 1 or more years after thyroidectomy and RAI ! Rate of clinical lymph node recurrence is 13 %

Given a % rate of PERSISTENT DISEASE And a 13 % risk of gross lymph node recurrence, THIS IMPLIES that one out of every 2 patients with Pythian Lymph nodes will eventually have a gross clinical recurrence

CUMULTATIVE RISK OF death due to papillary thyroid cancer after diagnosis of neck nodal metastasis was 10 %

Can adverse outcomes from Malignant lymph nodes be prevented? Because of a high rate of recurrent LN mets despite initial surgery and RAI its thought that pre op u/s might detect lymph node mets that wouldn’t be addressed otherwise ATA recommends pre op u/s for all thyroid cancer patients

How often can patients with neck lymph node mets be rendered disease free ? It ranges between 19 to 46 % Probably around 20% of patients can be rendered disease free with re-operation for PYTHIAN LYMPH NODES with a low but possible risks of operative complications

NOT CLEAR HOW MANY CLINICAL RECURRENCES THIS APPROACH OF RESECTING CANCEROUS LYMPH NODES PREVENTS SURVIVAL BENEFIT ALSO ISNT CLEAR

TAKE HOME POINTS Pre-operative ultrasound is essential because it guides surgery and decision to use remnant ablation even in “low risk” patients We don’t need a WBS for low risk patients if stimulated TG is negative and ultrasound is normal

TG positive scan negative patients should be evaluated with an ultrasound Ultrasound and needle biopsy TG washout is the most sensitive modality to evaluate recurrence

QUESTIONS/COMMENTS?